Cases
Cases 1 - 10 of 10
RSS Feed | View as table | Sort by last update
ARAGON PHARMACEUTICALS, INC. et al v. ZYDUS WORLDWIDE DMCC et al
as 2:2023cv01685
Plaintiff: ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC. and THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Defendant: ZYDUS WORLDWIDE DMCC, ZYDUS PHARMACEUTICALS (USA) INC. and ZYDUS LIFESCIENCES LIMITED
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Aragon Pharmaceuticals, Inc. et al v. Hetero Labs Limited Unit V et al
as 1:2022cv00696
Plaintiff: Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc., The Regents of the University of California and others
Defendant: Hetero Labs Limited Unit V and Hetero USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ARAGON PHARMACEUTICALS, INC. et al v. HETERO LABS LIMITED UNIT V et al
as 2:2022cv03212
Plaintiff: ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and others
Defendant: HETERO LABS LIMITED UNIT V and HETERO USA, INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
ARAGON PHARMACEUTICALS, INC. et al v. EUGIA PHARMA SPECIALITIES LIMITED et al We have downloadable decisions or orders for this case
as 2:2022cv03186
Plaintiff: ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and others
Defendant: EUGIA PHARMA SPECIALITIES LIMITED, AUROBINDO PHARMA USA, INC., AUROMEDICS PHARMA LLC and others
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Aragon Pharmaceuticals, Inc. et al v. Eugia Pharma Specialities Limited et al
as 1:2022cv00688
Defendant: Eugia Pharma Specialities Limited, Eugia Pharma Specialties Limited, Aurobindo Pharma USA, Inc. and others
Plaintiff: Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc., The Regents of the University of California and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Aragon Pharmaceuticals, Inc. et al v. Sandoz Inc.
as 1:2022cv00678
Plaintiff: Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc., The Regents of the University of California and others
Defendant: Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ARAGON PHARMACEUTICALS, INC. et al v. SANDOZ INC.
as 2:2022cv03044
Plaintiff: ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and others
Defendant: SANDOZ INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
ARAGON PHARMACEUTICALS, INC. et al v. ZYDUS WORLDWIDE DMCC et al
as 2:2022cv02964
Plaintiff: ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC. and SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH
Defendant: ZYDUS WORLDWIDE DMCC, ZYDUS PHARMACEUTICALS (USA) INC. and ZYDUS LIFESCIENCES LIMITED
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Aragon Pharmaceuticals, Inc. et al v. Lupin Limited et al
as 1:2022cv00637
Plaintiff: Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc. and Sloan Kettering Institute for Cancer Research
Defendant: Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ARAGON PHARMACEUTICALS, INC. et al v. LUPIN LIMITED et al
as 2:2022cv02825
Plaintiff: ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC. and SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH
Defendant: LUPIN LIMITED and LUPIN PHARMACEUTICALS, INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?